Liquidia (NASDAQ:LQDA) CEO Roger Jeffs Sells 6,428 Shares

Key Points

• Liquidia CEO Roger Jeffs sold 6,428 shares on May 27 at an average price of $62.18, for proceeds of about $399,693. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and Jeffs still directly owns more than 1.04 million shares.
• Jeffs has been steadily trimming his stake with multiple recent sales in May and April, including several 25,000-share transactions. These trades reflect a pattern of insider selling rather than a one-off transaction.
• Liquidia’s stock has surged and is near its 52-week high, closing around $62.03 with a 52-week range of $11.85 to $63.46. The company also posted strong recent earnings, beating estimates on both EPS and revenue, while analysts currently rate the stock a moderate buy.

Liquidia Corporation (NASDAQ:LQDA - Get Free Report) CEO Roger Jeffs sold 6,428 shares of the firm's stock in a transaction dated Wednesday, May 27th. The stock was sold at an average price of $62.18, for a total value of $399,693.04. Following the completion of the transaction, the chief executive officer directly owned 1,041,667 shares in the company, valued at $64,770,854.06. This trade represents a 0.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Roger Jeffs also recently made the following trade(s):

• On Tuesday, May 26th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $60.38, for a total value of $1,509,500.00.
• On Thursday, May 21st, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $61.13, for a total value of $1,528,250.00.
• On Tuesday, May 19th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $58.65, for a total value of $1,466,250.00.
• On Friday, May 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $57.04, for a total value of $1,426,000.00.
• On Wednesday, May 13th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $56.29, for a total value of $1,407,250.00.
• On Monday, May 11th, Roger Jeffs sold 25,000 shares of Liquidia stock. The stock was sold at an average price of $41.50, for a total value of $1,037,500.00.
• On Thursday, May 7th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $42.09, for a total value of $1,052,250.00.
• On Tuesday, May 5th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.10, for a total value of $1,002,500.00.
• On Friday, April 17th, Roger Jeffs sold 18,839 shares of Liquidia stock. The shares were sold at an average price of $40.60, for a total value of $764,863.40.
• On Wednesday, April 15th, Roger Jeffs sold 25,000 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total value of $1,003,500.00.

Liquidia Stock Performance

Shares of NASDAQ LQDA remained flat at $62.03 during trading hours on Thursday. The stock had a trading volume of 837,919 shares, compared to its average volume of 1,684,329. The company has a market capitalization of $5.52 billion, a PE ratio of 443.10 and a beta of 0.41. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18. The firm's 50 day moving average is $43.52 and its 200 day moving average is $38.05. Liquidia Corporation has a 52-week low of $11.85 and a 52-week high of $63.46.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The business's quarterly revenue was up 4187.1% on a year-over-year basis. Equities analysts anticipate that Liquidia Corporation will post 2.97 EPS for the current year.

Hedge Funds Weigh In On Liquidia

Large investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. purchased a new position in Liquidia during the 4th quarter valued at $25,000. Covestor Ltd lifted its holdings in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after buying an additional 359 shares during the period. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Liquidia in the 3rd quarter worth $30,000. FNY Investment Advisers LLC purchased a new stake in shares of Liquidia in the 3rd quarter worth $34,000. Finally, NewEdge Advisors LLC purchased a new stake in shares of Liquidia in the 2nd quarter worth $25,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Analyst Upgrades and Downgrades

LQDA has been the topic of several analyst reports. Needham & Company LLC boosted their target price on Liquidia from $54.00 to $70.00 and gave the company a "buy" rating in a research report on Monday, May 11th. HC Wainwright boosted their target price on Liquidia from $55.00 to $67.00 and gave the company a "buy" rating in a research report on Tuesday, May 12th. BTIG Research boosted their target price on Liquidia from $50.00 to $59.00 and gave the company a "buy" rating in a research report on Monday, May 11th. Wells Fargo & Company boosted their target price on Liquidia from $51.00 to $62.00 and gave the company an "overweight" rating in a research report on Tuesday, May 12th. Finally, Lifesci Capital upgraded Liquidia to a "strong-buy" rating in a report on Thursday, March 5th. Three research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $50.88.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.